The areas stained for glomerulus and tubular damage (tubular atrophy, interstitial inflammation, glomerular sclerosis, interstitial fibrosis), CD3e, CD68, and COL1α1 were significantly reduced after GQDs pre‐treatment (Figure 4C). This evidence concerns the gene CD3E and glomerulosclerosis.